stars 1 stars 2 stars 3

Drugs Intelligence 𝗗𝗮𝘁𝗮-𝗗𝗿𝗶𝘃𝗲𝗻 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 DI has developed an exclusive technological platform that aggregates unique data sets and applies manipulation, unification, and deployment of the data to a BI, AI, and ML platform. we provide the solution for the Identification and prediction of drug shortages globally. we are Monitoring, sourcing, and cross-matching products to address unmet medical needs. 𝗩𝗶𝘀𝗶𝗼𝗻 Our company’s vision and focus are based on Dr. Shlomo Sadoun’s thesis “Six pillar of successful launches of orphan drugs globally" utilizing cutting edge technologies to support smart business decisions that will lead to better healthcare solutions. 𝗢𝘃𝗲𝗿𝘃𝗶𝗲𝘄 - Our unique platform allows us to extract all relevant Data identifying the most lucrative data set or article using advance technologies. - Collect historical data, risk factors and causes data using ML allows the model to predict prevalence values based on systematic research analysis validated by designated scientists. - Monitor markets and collect real-time intelligence and Rare Diseases Data. - Making Data-driven decisions and creating business opportunities. 𝗧𝗵𝗲 𝗖𝗼𝗺𝗽𝗮𝘀𝘀 The compass essence is to guide orphan drugs companies towards excellent launch of their orphan drugs, based on the orphan drug 6 pillars of success methodology. The Compass providing eagle eye view of the orphan drug market opportunities in 65 countries and counting, with a mission of answering unmet needs for patients and their caregivers dealing with rare disease.

DrugsIntel Questions

Elad Lapides is the CEO of DrugsIntel.

4 people are employed at DrugsIntel.

Top DrugsIntel Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users